FDA Panel Rejects Weight-Loss Pill
July 15, 2010, 3:12 PM
GAITHERSBURG, MD -
A Food and Drug Administration panel has voted 9-7 against Vivus Inc.'s Qnexa citing the experimental obesity treatment's negative side effects.
Federal health advisers say the negative effects on concentration and memory outweigh its ability to help patients lose
The vote deals a major setback to the Mountainview, CA drugmaker which is racing two other small California drugmakers to
market its weight-loss pill.
The FDA will consider the panel's recommendation and make a final decision later this year.
The agency has not approved a new prescription weight loss pill in over a decade, and currently available drugs have limited effectiveness and worrisome side effects.
© 2010 Associated Press. All rights reserved. Material may not be redistributed.
5/19/2015 6:05 PM
It was supposed to be an unforgettable concert, but a woman says she cannot remember it because she believes someone drugged her.
5/19/2015 12:22 PM
Video of a young boy getting a hug from a chicken is collecting a flock of fans.
5/22/2015 11:04 AM
In February, Drueppel admitted she had a relationship with a student while working as a teacher at a Sioux Falls middle school.
5/21/2015 5:42 AM
Police in Omaha, Nebraska, say a shootout between officers and a convicted felon has left an officer and the suspect dead.
5/23/2015 5:14 PM
Sioux Falls Fire Rescue put out a fire on the playground of Hawthorne Elementary Saturday afternoon that damaged the school.